Poly Medicure Limited announced Financial Results for its Q2 FY19-20 ended September 30, 2019.
The Company's net profit increased by 86.87 per cent from Rs 14.86 Crores in the same quarter previous year to Rs 27.02 Crores in the end of September 30, 2019. Revenue has increased by 11.51 per cent from Rs 150.58 Crores to Rs 168.23 Crores.
EBIDTA increased by 17.95 per cent from Rs 38.61 crores to 45.54 crores. The company has reported EPS of Rs 3.22 for the period ended September 30, 2019 as compared to Rs 2.24 for the period ended June 30, 2019.
"The Company has enhanced its focus on India Business due to increased healthcare activities because of implementation of Ayushman Bharat by Government of India. Almost 18,000 hospitals have already empanelled under Ayushman Bharat. The company welcomes the Ministry of Health's recent notification to regulate all medical devices. This will bring all medical devices under a regulatory environment; a positive for the industry as it enhances patient safety and standards," said Himanshu Baid, MD, Poly Medicure Limited.
With a turnover of 600+ crores, Poly Medicure Limited (POLYMED) is an Indian Medical Device Company with over 20 years of experience in manufacturing high-quality medical devices. It is one of the leading manufacturer and exporter of medical devices with focus on innovation, safety and quality. The company has been awarded as the 'India Medical Devices Company of the Year' by Department of Pharmaceutical Ministry of Chemical and Fertilizer, Government of India.
The company has recently set up a facility to make Renal Care/Dialysis products in India which are 100 per cent import substitution. The company has 5 domestic (3 Faridabad and one each in Jaipur and Haridwar) and 3 overseas (China, Egypt and Italy) manufacturing facilities.
This content is provided by NewsVoir. ANI will not be responsible in any way for the content of this article.